Bio Medica Laboratories SME IPO Subscription Status
Bio Medica Laboratories SME IPO closed on 25 May 2026 with an overall subscription of 2.31x based on shares applied. QIB demand came in at 15.94x, NII at 1.41x, and retail at 2.92x.
Allotment will be finalised on 26 May 2026. The stock is scheduled to list on NSE and BSE on 29 May 2026.
Issue Price
Rs 139.00
GMP Today
Rs -9.00 (-6.47%)
Overall Subscription
2.31x
Issue Size
₹52.43 Cr
Allotment Date
26 May 2026
Listing Date
29 May 2026
Bio Medica Laboratories SME IPO Subscription by Amount
Category-wise subscription based on amount applied at issue price Rs 139.00
| Category | Amount Offered | Amount Applied | Subscription |
|---|---|---|---|
| QIB | Rs 50.04 L | Rs 7.98 Cr | 15.94x |
| FII | - | Rs 7.98 Cr | - |
| DFI | - | - | - |
| Mutual Funds | - | - | - |
| Other | - | - | - |
| NII | Rs 24.39 Cr | Rs 34.40 Cr | 1.41x |
| bNII (above Rs 10L) | Rs 16.26 Cr | Rs 16.58 Cr | 1.02x |
| Corporate | - | Rs 2.63 Cr | - |
| Individual | - | Rs 12.45 Cr | - |
| Other | - | Rs 1.50 Cr | - |
| sNII (Rs 2L to Rs 10L) | Rs 8.13 Cr | Rs 17.82 Cr | 2.19x |
| Corporate | - | Rs 8.34 L | - |
| Individual | - | Rs 17.15 Cr | - |
| Other | - | Rs 58.38 L | - |
| IND | Rs 24.91 Cr | Rs 72.67 Cr | 2.92x |
| Total | Rs 49.80 Cr | Rs 115.05 Cr | 2.31x |
Bio Medica Laboratories SME IPO Subscription by Applications
Category-wise subscription based on applications received
| Category | Applications Offered | Applications Received | Subscription |
|---|---|---|---|
| QIB | 36 | 6 | 0.17x |
| FII | - | 6 | - |
| DFI | - | - | - |
| Mutual Funds | - | - | - |
| Other | - | - | - |
| NII | 585 | 457 | 0.78x |
| bNII (above Rs 10L) | 390 | 35 | 0.09x |
| Corporate | - | 1 | - |
| Individual | - | 32 | - |
| Other | - | 2 | - |
| sNII (Rs 2L to Rs 10L) | 195 | 422 | 2.16x |
| Corporate | - | 2 | - |
| Individual | - | 406 | - |
| Other | - | 14 | - |
| IND | 896 | 2,614 | 2.92x |
| Total | 1,517 | 3,077 | 2.03x |
What Do These Subscription Numbers Mean?
A subscription of 2.31x by shares means the IPO received bids for 2 times the shares reserved. Allotment odds depend on application count in each category, not share volume.
Here is what each category number tells you:
QIB at 15.94x by shares: This is the strongest signal on the page. QIBs are institutional investors, mutual funds, foreign institutions, and banks. When they subscribe at 15.94x, it reflects serious institutional conviction.
NII at 0.78x by applications: NII includes high net worth individuals applying above Rs 2 lakh. Proportional allotment uses application subscription. bNII came in at 0.09x and sNII at 2.16x by applications. Share subscription was 1.41x. Allotment uses application count, not share volume.
At 2.92x subscription by applications, approximately 1 in 3 retail applicants can expect an allotment (~34% per application). Retail allotment is done by lottery when oversubscribed.
Bio Medica Laboratories SME IPO Allotment Chances
Allotment odds below use application subscription (number of bids received), not share or amount subscribed.
Retail (IND)
- •Application subscription: 2.92x.
- •Allotment odds: about 1 in 3 (~34% chance per application).
- •Method: Lottery. If allotted, you receive at least one lot.
- •One application per PAN. Multiple eligible accounts in a household can improve overall family odds, not individual odds.
SHNI (Rs 2 lakh to Rs 10 lakh)
- •Application subscription: 2.16x.
- •Allotment odds: about 1 in 2 for a minimum-lot application (~46% of the applied lot on average).
- •Method: Proportional. Shares allotted are based on your bid size, not a lottery.
BHNI (above Rs 10 lakh)
- •Application subscription: 0.09x.
- •Share subscription was 1.02x. Allotment uses application count, not share volume.
Check the Bio Medica Laboratories SME IPO Allotment Status page from 26 May 2026 for your allotment result.
Bio Medica Laboratories SME IPO Day-wise Subscription
| Day | QIB | NII | Retail | Overall |
|---|---|---|---|---|
| Day 1 - 21 May 2026 | 15.94x | 0.03x | 1.09x | 0.72x |
| Day 2 - 22 May 2026 | 15.94x | 0.28x | 1.42x | 1.01x |
| Day 3 - 25 May 2026 | 15.94x | 1.30x | 2.92x | 2.26x |
Bio Medica Laboratories SME IPO Key Dates
| Event | Date |
|---|---|
| IPO Open Date | 21 May 2026 |
| IPO Close Date | 25 May 2026 |
| Allotment Date | 26 May 2026 |
| Refund Initiation | 27 May 2026 |
| Share Credit to Demat | 27 May 2026 |
| Listing Date | 29 May 2026 |
| Minimum Investment | Rs 2,78,000.00 |
| Lot Size | 1000 shares |
About Bio Medica Laboratories SME
Bio Medica Laboratories Limited, incorporated in 2015, is an Indian pharmaceutical manufacturer specializing in parenteral formulations. The company develops and contract-manufactures a wide range of ethical drugs, generic medicines, and over-the-counter (OTC) products in the form of liquid and dry powder injectables. Operating entirely on a B2B contract manufacturing model, it designs multi-dose and single-dose injectables for both human and veterinary applications.
Understanding Subscription Categories
QIB - Qualified Institutional Buyers
Includes foreign institutional investors, domestic financial institutions, mutual funds, and other qualified institutions. QIB demand is considered the most reliable indicator of institutional confidence in an IPO.
NII - Non-Institutional Investors
High net worth individuals applying above Rs 2 lakh. Divided into bNII (above Rs 10 lakh) and sNII (Rs 2 lakh to Rs 10 lakh). NII allotment is proportional.
IND - Individual Investors
Investors applying up to Rs 2 lakh per PAN. Allotment is by lottery when oversubscribed. Minimum one lot per successful applicant.
Bio Medica Laboratories SME IPO GMP Today
Live GMP, listing price estimate, and listing gain
Bio Medica Laboratories SME IPO Allotment Status
Check allotment result on allotment date
Bio Medica Laboratories SME IPO Details
Financials, peers, strengths, and review
All IPO Subscription Status
Subscription for all active IPOs
Bio Medica Laboratories SME IPO Subscription FAQs
What is Bio Medica Laboratories SME IPO subscription status today?
Bio Medica Laboratories SME IPO subscription closed on 25 May 2026 with overall subscription of 2.31x (by shares) as of 17 July 2026, 2:01 AM IST. QIB 15.94x, NII 0.78x, IND 2.92x.
What is the overall subscription of Bio Medica Laboratories SME IPO?
Bio Medica Laboratories SME IPO is subscribed 2.31x overall by shares at close on 25 May 2026. QIB 15.94x, NII 0.78x, and IND 2.92x.
What is Bio Medica Laboratories SME IPO QIB subscription?
Bio Medica Laboratories SME IPO QIB (Qualified Institutional Buyers) subscription is 15.94x by shares. QIB includes mutual funds, FIIs, banks, and other institutions.
What is Bio Medica Laboratories SME IPO IND subscription?
Bio Medica Laboratories SME IPO IND subscription is 2.92x by applications. Minimum retail bid is up to Rs 2 lakh per PAN.
What is Bio Medica Laboratories SME IPO NII subscription?
Bio Medica Laboratories SME IPO NII (Non-Institutional Investors) subscription is 0.78x by applications. NII covers bids above Rs 2 lakh.
What are allotment chances in Bio Medica Laboratories SME IPO for retail?
At 2.92x subscription by applications, approximately 1 in 3 retail applicants can expect an allotment (~34% per application). Allotment is done by lottery.
When is Bio Medica Laboratories SME IPO allotment date?
Bio Medica Laboratories SME IPO allotment date is 26 May 2026. Check Bio Medica Laboratories SME IPO Allotment Status on IPOwiz from that day using your PAN.
When does Bio Medica Laboratories SME IPO subscription close?
Bio Medica Laboratories SME IPO subscription closed on 25 May 2026. No new applications are accepted after the close.
What is Bio Medica Laboratories SME IPO GMP today?
Bio Medica Laboratories SME IPO GMP is ₹-9 today (-6.47% over issue price ₹139). See live GMP on the Bio Medica Laboratories SME IPO GMP Today page.
What is Bio Medica Laboratories SME IPO issue price and lot size?
Bio Medica Laboratories SME IPO issue price is ₹139 per share. Lot size is 1000 shares. Minimum investment is ₹2,78,000 per lot (minimum 2 lots for SME). Issue size: ₹52.43 Cr.
When is Bio Medica Laboratories SME IPO listing date?
Bio Medica Laboratories SME IPO listing date is 29 May 2026 on NSE and BSE. Allotment is on 26 May 2026.
How does subscription affect Bio Medica Laboratories SME IPO allotment?
Allotment odds in Bio Medica Laboratories SME IPO depend on application subscription in each category, not share volume. Retail uses lottery when oversubscribed. NII uses proportional allotment by applications. At 2.31x overall, competition is moderate.
For allotment results from 26 May 2026, visit the Bio Medica Laboratories SME IPO Allotment Status page. For listing day updates on 29 May 2026, download the IPOwiz App.
Reviewed by Dinesh Agrawal
15+ years in Indian capital markets and IPO research. Subscription data verified before publish.